…fast routes to receive and send fresh samples to their network of collaborators. “The first time we thought it was so cool to just walk out of the lab and…
…drugs to always make it to the market. Nevertheless, as different kinds of therapies seem to be on the horizon at present, it is more likely that with the ramped-up…
…through alternative pathways, rather than activating telomerase. This mechanism is known as the alternative lengthening of telomeres (ALT). To date, there is no clinically approved targeted treatment for ALT cancers….
…which had an activated brainstem learned faster and responded to the tasks quicker. These rats completed the auditory task within three days while those that did not receive the boost…
…This makes the drug the first biological treatment for patients with COPD in the U.S. Dupixent is a fully human monoclonal antibody that inhibits the signaling of the IL4 and…
…while also destroying the tumor’s surrounding ‘helper cells’. Traditional chemotherapeutics in this area have only targeted tumor cells and not the surrounding helper cells, and therefore their treatment effect is…
…HeLa cells. They looked at the effect of heating through nanoHT, and found that at a temperature increment of about 11.4°C, the heated HeLa cells died after only a few…
…would be toxic for the body. So, instead they turned to nature’s toolkit for potent biomotors, and came up with….Sperm. Two types of motion for unicellular microorganisms. Sperm cells have…
…cells and fluid. Their approach offers a promising alternative to current 3D printing techniques that tend to use heat or UV light, which damage living cells. Tissue engineering has the…
The Hamburg-based Evotec spinout Breakpoint Therapeutics is working on cancer treatments that block the ability of tumor cells to repair their own DNA. In the last decade, a new class…
…dynamic at the moment. But what can we expect in the years to come? Indeed, Ghoshal thinks it is this blend that makes the field so promising and prone to…
…a limited time, Takeda will also have the option of acquiring Adaptate Biotherapeutics. Gamma delta T-cells are a rare type of immune T-cells. Unlike the T-cells used in most cancer…